Objectives-To document the nature, distribution, and frequency of dystonic symptoms in progressive supranuclear palsy (PSP). Methods-Charts and videotapes of all clinically diagnosed patients with PSP seen between 1983 and 1993 were reviewed and the occurrence, nature, and distribution of all dystonic symptoms were recorded.
tribution, and frequency of dystonic symptoms in progressive supranuclear palsy (PSP). Methods-Charts and videotapes of all clinically diagnosed patients with PSP seen between 1983 and 1993 were reviewed and the occurrence, nature, and distribution of all dystonic symptoms were recorded. Results-Of 83 identified cases 38 had some dystonic features. Twenty (24%) had blepharospasm (one was induced by levodopa), 22 (27%) had limb dystonia (one was induced by electroconvulsive therapy and another by levodopa), 14 (17%) had axial dystonia in extension, one had oromandibular dystonia induced by levodopa, and two had other cranial dystonias. Six patients had limb dystonia as an early or presenting feature, sometimes leading to misdiagnosis of cortical-basal ganglionic degeneration. All three patients who had postmortem confirmation of the diagnosis had other concurrent disease. One patient with bilateral limb dystonia and blepharospasm had evidence of previous hydrocephalus and severe arteriosclerotic changes. One with arm dystonia also had cerebrovascular disease and one with hemidystonia also had rare swollen chromatolytic neurons in the frontotemporal cortex.
Conclusions-Dystonia is a common manifestation of PSP. Limb dystonia is particularly common and may indicate the presence of concurrent disease. When dystonia occurs in PSP, dopaminergic medication should be cautiously reduced or discontinued to rule out the possibility of treatment induced symptoms. Since progressive supranuclear palsy (PSP) was first characterised in 1964,1 dystonic manifestations have been reported only sporadically.2-7 "Axial dystonia in extension" is the only such manifestation which has been emphasised; however, the pathogenesis of this tonic, rigid extended posture is probably distinct from other forms of dystonia. Blepharospasm has also been reasonably well recognised in this setting, whereas limb dystonia, oromandibular dystonia, and treatment induced dystonia have all but been ignored. In reviewing a large series of patients with PSP, we were impressed with the frequency of dystonia and report our findings below.
Methods
The charts of all patients with a diagnosis of PSP who were seen in the Toronto Hospital movement disorders clinic between January 1983 and February 1993 were reviewed. All videotaped examinations available on these patients were reviewed. The clinical diagnosis was considered correct if the patient had a progressive, non-familial neurodegenerative disorder with onset after the age of 40 which included supranuclear ophthalmoplegia with downgaze abnormalities and at least two of the following features: postural instability with backward falls, pseudobulbar palsy, bradykinesia and rigidity, frontal lobe signs, or axial dystonia and rigidity (Lees' criteria Limb involvement was the most common dystonic manifestation in our PSP population (22 patients, 27%) and hemidystonia the most frequent distribution (nine patients (11%)). Although in many instances the precise limb posture was not recorded, a "pointing gun" posture, with extension of the index finger and thumb, was often noted. In four patients, hemidystonia was a very early or presenting feature of their disease. Two were initially diagnosed elsewhere as having cortical-basal ganglionic degeneration because of the pronounced unilateral (left sided) dystonia. However, these patients had a vertical supranuclear gaze palsy at presentation and no cortical sensory loss or stimulus sensitive myoclonus. Significant limb apraxia was also absent but was difficult to assess due to the pronounced disability caused by their dystonia, bradykinesia, and rigidity. One patient, last seen six years after symptom onset, remains free of manifestations of cortical-basal ganglionic degeneration. The other died five years after onset of symptoms. Postmortem examination disclosed the typical pathological abnormalities of PSP. In addition, rare swollen chromatolytic neurons were noted in the frontotemporal cortex and there was neuronal loss and gliosis in the left motor cortex and right posterior middle frontal gyrus. These findings, although suggestive of cortical-basal ganglionic degeneration, have been described in PSP"I-"3 and due to the overwhelming predominance of the findings of this disorder, the final neuropathological diagnosis was that of "atypical PSP".'4
Single limb involvement occurred in eight patients (10%). In seven, an arm was involved. In one the patient developed dystonia in his left leg during a course of electroconvulsive therapy.'5 Within one month of cessation of that treatment, this symptom resolved. It spontaneously recurred and gradually worsened over the subsequent 18 months of follow up. One patient developed right arm dystonia with associated choreic movements while receiving levodopa/carbidopa. All involuntary movements ceased on discontinuation of the drug.
In two other cases, arm dystonia was the initial manifestation of disease. One of these, with right arm involvement, died after an eight year history of gradually progressive neurological dysfunction compatible with a clinical diagnosis of PSP. Postmortem examination, in addition to the typical pathological changes of PSP, showed severe arteriosclerosis with microinfarcts in the left caudate, left lateral thalamus, right dorsomedial thalamus, and multiple neocortical regions.
The one patient with dystonic posturing in all four limbs late in the course of his illness also had PSP confirmed at necropsy. This patient is reported elsewhere.'6 He presented at age 69 with incontinence, gait impairment, falls, and cognitive dysfunction. Brain CT suggested normal pressure hydrocephalus and ventricular shunting was performed. His symptoms improved greatly for a few months; however, his gait then worsened, dysphagia and dysarthria occurred, and he developed a vertical supranuclear gaze palsy, blepharospasm, and mild bilateral limb dystonia. He died aged 75 and in addition to the typical findings of PSP, his postmortem examination showed evidence of previous hydrocephalus and severe arteriosclerotic changes in the white matter and deep grey structures with numerous small infarcts (1-8 mm in diameter) bilaterally in the centrum semiovale and basal ganglia.
Whereas we do not consider the neck posture typically seen in PSP to be dystonic in nature, as some authors consider it such, we recorded the frequency of this feature. Fourteen patients (17%) were documented as having "axial dystonia in extension". This was characterised by constant extensor posturing of the neck with severe nuchal rigidity. No patient had phasic or intermittent dystonic neck movements, improvement with antagonistic gestures, "morning benefit", or other clinical features characteristic of classic cervical dystonia.
With the retrospective nature of this review, the lack of a consistent approach to treatment, and the complex symptomatology that our patients experienced, an accurate assessment of the response of the patients' dystonia to medical management could not be obtained. None of the patients receiving levodopa or dopamine agonists were reported to experience a lessening of their dystonic symptoms. Rarely, patients with limb dystonia or blepharospasm were noted to have some beneficial response to tricyclic agents whereas only those who received botulinum toxin injections for blepharospasm clearly experienced a good response to therapy. No patient in this series with any other form of dystonia received botulinum toxin injections. Discussion Dystonia was first reported in association with PSP with the initial description of the disorder by Steele, Richardson, and Olszewski in 1964.1 Whereas they emphasised "axial dystonia in extension", one of their patients also showed unilateral arm dystonia.
Axial dystonia in extension is by far the most commonly recognised and reported "dystonic" manifestation of PSP. De Bruin and Lees noted that 48-3% of all necropsied patients with PSP reported in the literature had axial dystonia of some sort. 17 The posturing seen in this condition, however, lacks the typical features of dystonia and many authors think that this term should be avoided. 8 18 The neck positioning in PSP tends to be fixed and does not alter with posture or activity as idiopathic dystonia does. Patients fail to show sensory tricks for improving the posturing, diurnal variation ("morning benefit") is absent, and painful neck spasms and hypertrophic muscles are not seen. For these reasons, nuchal rigidity in extension would be a more appropriate term. We would reserve the term "axial dystonia" for those rare cases reported in which torticollis was described.1' 20 In our series, no patient had such neck movements. Fourteen (17%), however, were noted to have overt nuchal rigidity in extension. This is likely an underrepresentation of the true prevalence of this sign as the position of the neck was not always specified and so milder examples may have been overlooked or not documented.
The most widely accepted dystonic manifestation of PSP is blepharospasm.2' In two clinic based series, blepharospasm was noted in between 8% and 23% of cases.22 23 Golbe et al reported a community based series of 38 patients with PSP in whom 10 (26%) had blepharospasm, or "levator inhibition" ("apraxia of eyelid opening"), or both.24 It 28 of 104 patients had blepharospasm "or other facial spasms".22 Elsewhere they noted that 24 of these had blepharospasm but there is no mention of the nature of the "facial spasms" in the other four or whether any of the patients with blepharospasm had other associated facial movements. Hayashi et al described a case of otherwise typical PSP in which the patient developed tonic contraction of the orbicularis oris and palatal muscles when attempting to make certain sounds.3' Although they considered that this was analogous to apraxia of eyelid opening, it may represent a form of facial dystonia.
Whereas one of our patients had a dystonic grin with intermittent repetitive semirhythmical movements of the muscles of her lower face and one had sustained involuntary smiling which appeared dystonic, many patients had facial "stiffness" which was not clearly dystonic in nature. In these patients, the facial stiffness was accompanied by a concomitant increase in facial reflexes and we therefore considered this appearance to be due to spasticity rather than dystonia. Although the characteristic sustained eyebrow elevation commonly seen in PSP may represent dystonic involvement of the frontalis muscle, it could also represent a variable combination of spasticity, rigidity, and a response to difficulty with eyelid opening. In view of the uncertainty of classification, we chose, for the purpose of this report, not to record the furrowing of the brow or the deepening of the nasolabial folds as features of dystonia.
No patient in this series had spontaneous oromandibular dystonia. One patient with long standing PSP, however, had jaw closure dystonia and blepharospasm while taking levodopa. On discontinuation of this medication, both dystonic symptoms resolved completely. It is important to emphasise that the cause and effect relation between the dystonic symptoms and levodopa therapy was not readily apparent in this patient until long term levodopa treatment was withdrawn. The same is true of the one patient with limb dystonia induced by levodopa. Given our experience, the potential role of medication, especially levodopa, must be considered when dealing with dystonia in patients with PSP.
Despite a lack of emphasis on this feature in the literature, we found limb involvement to be the most frequent type of dystonia in our series. When Steele, Richardson, and Olszewski first described this condition in 1964, they reported seven necropsied cases and two clinical cases. One of the necropsied cases had "athetoid posturing of the limbs"' and one of the clinical cases, which subsequently came to necropsy, developed a "hemiplegic dystonic posture". 32 Very little emphasis has been placed on this feature since then. Jankovic et al reported the only large clinical series in which limb dystonia was not a rare or absent sign. 22 Although referral bias in this series may have resulted in the accrual of a higher proportion of atypical cases and, consequently, an overestimate of the frequency of dystonia in PSP, our findings clearly indicate that dystonia is a common manifestation of PSP. Limb dystonia, although sometimes indicative of other concurrent pathology, may be the presenting symptom of this disorder. Recognition of this may avoid misdiagnosis of cortical-basal ganglionic degeneration or some other condition.
Our series also shows the potential for dopaminergic medication to induce dystonia in PSP. Although this may be an infrequent cause, when dystonia is noted in patients on such medications, the dosage should be cautiously reduced or eliminated in an attempt to establish the role of drug therapy in the causation of this disabling complication.
Further study of community based populations with associated clinical-pathological correlation is necessary if the true frequency and anatomical substrates of the dystonic manifestations of this disorder are to be clarified.
We are indebted to Dr C Bergeron for the careful neuropathological assessment of the cases described. 
